Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand Obese mice with type 2 diabetes

Life Sciences

Volumn 85, Issue 23-26, 2009, Pages 775-781

  Wu, Kuo Chen ^a   Pan, Huei Ju ^b   Yin, Hsiang Shu ^a   Chen, Mei Ru ^a   Lu, Shao Chun ^a   Lin, Chun Jung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

BBB; Caveolin; Diabetes; NZO; P glycoprotein

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; GLYCOPROTEIN P; INSULIN; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN CELL; CELL CULTURE; CONTROLLED STUDY; CORPUS STRIATUM; DIABETIC OBESITY; ENDOTHELIUM CELL; EXTRACELLULAR FLUID; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; MOUSE; NEW ZEALAND BLACK MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CAVEOLINS; CELLS, CULTURED; CORPUS STRIATUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED STRAINS; MICE, OBESE; P-GLYCOPROTEIN; RATS; REFERENCE STANDARDS; UP-REGULATION;

ANIMALIA; MUS; RATTUS;

EID: 70649112119     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.10.014     Document Type: Article

References (50)

1. Barakat S., Demeule M., Pilorget A., Régina A., Gingras D., Baggetto L.G., and Béliveau R. Modulation of P-glycoprotein function by caveolin-1 phosphorylation. Journal of Neurochemistry 101 (2007) 1-8
2. Batetta B., Mulas M.F., Petruzzo P., Putzolu M., Bonatesta R.R., Sanna F., Cappai A., Brotzu G., and Dessi S. Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cellular and Molecular Life Sciences 58 (2001) 1113-1120
3. Bauer B., Hartz A.M., Fricker G., and Miller D.S. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Molecular Pharmacology 66 (2004) 413-419
4. Bauer B., Hartz A.M.S., and Miller D.S. Tumor necrosis factorα and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Molecular Pharmacology 71 (2007) 667-675
5. Bentires-Alj M., Barbu V., Fillet M., Chariot A., Relic B., Jacobs N., Gielen J., Merville M.P., and Bours V. NF-kappa B transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22 (2003) 90-97
6. Bielschowsky M., and Goodall C.M. Origin of inbred NZ mouse strains. Cancer Research 30 (1970) 834-836
7. Bucci M., Roviezzo F., Brancaleone V., Lin M.I., Di Lorenzo A., Cicala C., Pinto A., Sessa W.C., Farneti S., Fiorucci S., and Cirino G. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (2004) 721-726
8. Burant C.F., Flink S., DePaoli A.M., Chen J., Lee W.S., Hediger M.A., Buse J.B., and Chang E.B. Small intestine hexose transport in experimental diabetes. Journal of Clinical Investigation 93 (1994) 578-585
9. Chen C.J., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., and Roninson I.B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47 (1986) 381-389
10. Cohen A.W., Razani B., Wang X.B., Combs T.P., Williams T.M., Scherer P.E., and Lisanti M.P. Caveolin-1 deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology 285 (2003) C222-C235
11. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., and Bertino J.R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 695-698
12. Demeule M., Jodoin J., Gingras D., and Beliveau R. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Letters 466 (2000) 219-224
13. Deregowski V., Delhalle S., Benoit V., Bours V., and Merville M.P. Identification of cytokine-induced nuclear factor-kappa B target genes in ovarian and breast cancer cells. Biochemical Pharmacology 64 (2002) 873-881
14. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., and Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293 (2001) 2449-2452
15. Dyer J., Wood I.S., Palejwala A., Ellis A., and Shirazi-Beechey S.P. Expression of monosaccharide transporters in intestine of diabetic humans. American Journal of Physiology 282 (2002) G241-G248
16. Fojo A.T., Ueda K., Slamon D.J., Poplack D.G., Gottesman M.M., and Pastan L. Expression of a multidrug-resistance gene in human tumors and tissues. Proceedings of the National Academy of Sciences of the United States of America 84 (1987) 265-269
17. Gangopadhyay A., Thamotharan M., and Adibi S.A. Regulation of oligopeptide transporter (Pept-1) in experimental diabetes. American Journal of Physiology 283 (2002) G133-G138
18. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., and Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
19. Hayashi T., Juliet P.A.R., Miyazaki A., Ignarro L., and Iguchi A. High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis. Biochimica Biophysica Acta 1772 (2007) 364-372
20. Hileman S.M., Pierroz D.D., Masuzaki H., Bjørbek C., El-Haschimi K., Banks W.A., and Flier J.S. Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 143 (2002) 775-783
21. Hirano M., Hirai S., Mizuno K., Osada S., Hosaka M., and Ohno S. A protein kinase C isozyme, nPKC epsilon, is involved in the activation of NF-kappa B by 12-O-tetradecanoylphorbol-13-acetate (TPA) in rat 3Y1 fibroblasts. Biochemical and Biophysical Research Communications 206 (1995) 429-436
22. Haskell B.D., Flurkey K., Duffy T.M., Sargent E.E., and Leiter E.H. The diabetes-prone NZO/H1Lt strain. I. Immunophenotypic comparison to the related NZB/B1NJ and NZW/LacJ strains. Laboratory Investigation 82 (2002) 833-842
23. Inoguchi T., Xia P., Kunisaki M., Higashi S., Feener E.P., and King G.L. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. American Journal of Physiology 267 (1994) E369-E379
24. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
25. Jang E.H., Park C.S., Lee S.K., Pie J.E., and Kang J.H. Excessive nitric oxide attenuates leptin-mediated signal transducer and activator of transcription 3 activation. Life Sciences 80 (2007) 609-617
26. Jodoin J., Demeule M., Fenart M., Cecchelli L., Farmer S., Linton K.J., Higgins C.F., and Beliveau R. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. Journal of Neurochemistry 87 (2003) 1010-1023
27. Kim I.W., Booth-Genthe C., and Ambudkar S.V. Relationship between drugs and functional activity of various mammalian P-glycoproteins (ABCB1). Mini-Reviews in Medicinal Chemistry 8 (2008) 193-200
28. Komers R., Schutzer W.E., Reed J.F., Lindsley J.N., Oyama T.T., Buck D.C., Mader S.L., and Anderson S. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Diabetes 55 (2006) 1651-1659
29. Lam T.Y., Seto S.W., Lau Y.M., Au L.S., Kwan Y.W., Ngai S.M., and Tsui K.W. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic + db/+db mice. European Journal of Pharmacology 546 (2006) 134-141
30. Leiter E.H., Reifsnyder P.C., Flurkey K., Partke H.J., Junger E., and Herberg L. NIDDM genes in mice. Deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes 47 (1998) 1287-1295
31. Leiter E.H., and Reifsnyder P.C. Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Diabetes 53 (2004) S4-S11
32. + in rat brain endothelial cells. Life Sciences 81 (2007) 664-672
33. Lu S.C., Wu H.W., Lin Y.J., and Chang S.F. The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A. American Journal of Physiology 296 (2009) C1133-C1139
34. Maeng H.J., Kim M.H., Jin H.E., Shin S.M., Tsuruo T., Kim S.G., Kim D.D., Shim C.K., and Chung S.J. Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: Evidence for the involvement of nuclear factor-κB, a nitrosative stress-sensitive transcription factor, in the regulation. Drug Metabolism and Disposition 35 (2007) 1996-2005
35. Ng W.F., Sarangi F., Zastawny R.L., Veinot-Drebot L., and Ling V. Identification of members of the P-glycoprotein multigene family. Molecular and Cellular Biology 9 (1989) 1224-1232
36. Ortlepp J.R., Kluge R., Giesen K., Plum L., Radke P., Hanrath P., and Joost H.G. A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse. European Journal of Clinical Investigation 30 (2000) 195-202
37. Pan H.J., Reifsnyder P., Vance D.E., Xiao Q., and Leiter H.H. Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models of type 2 diabetes. Diabetes 54 (2005) 1854-1862
38. Pang A., Au W.Y., and Kwong Y.L. Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow. Leukemia Research 28 (2004) 973-977
39. Pardridge W.M., Triguero D., and Farrell C.R. Down regulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39 (1990) 1040-1044
40. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates, second ed. Elsevier, Academic Press, San Diego, CA, 2004.
41. Petkov P.M., Ding Y., Cassell M.A., Zhang W., Wagner G., Sargent E.E., Asquith S., Crew V., Johnson K.A., Robinson P., Scott V.E., and Wiles M.V. An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Research 14 (2004) 1806-1811
42. Razani B., Woodman S.E., and Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacological Reviews 54 (2002) 431-467
43. Reifsnyder P.C., and Leiter E.H. Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. Diabetes 51 (2002) 825-832
44. Ryan M.J., McLemore G.R., and Hendrix S.T. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus. Hypertension 48 (2006) 988-993
45. Thevenod F., Friedmann J.M., Katsen A.D., and Hauser I.A. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-κB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. The Journal of Biological Chemistry 275 (2000) 1887-1896
46. Virgintino D., Robertson D., Errede M., Benagiano V., Girolamo F., Maiorano E., Roncall L., and Bertossi M. Expression of P-glycoprotein in human cerebral cortex microvessel. The Journal of Histochemistry and Cytochemistry 50 (2002) 1671-1676
47. Yeh W.L., Lin C.J., and Fu W.M. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed hypoxia. Molecular Pharmacology 73 (2008) 170-177
48. Yoshinari K., Takagi S., Sugatani J., and Niwa M. Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice. Biological and Pharmaceutical Bulletin 29 (2006) 1634-1638
49. Yumoto R., Murakami T., Nakamoto Y., Hasegawa R., Nagai J., and Takano M. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. Journal of Pharmacology and Experimental Therapeutics 289 (1999) 149-155
50. Zhou G., and Kuo M.T. NF-κB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. The Journal of Biological Chemistry 272 (1997) 15174-15183